Holdings

Opaleye Management Inc.

As of Sep 30, 2026, Opaleye Management Inc. reported 53 positions worth US$776M. Largest: Eton Pharmaceuticals, Inc., Disc Medicine, Inc. and Harrow, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Eton Pharmaceuticals, Inc.2.44MUS$126M−420KSep 30, 2026
Disc Medicine, Inc.1.09MUS$71.7M+240KSep 30, 2026
Harrow, Inc.2.1MUS$64.8M−295KSep 30, 2026
Liquidia Corporation2.11MUS$63.8M−338KSep 30, 2026
MeiraGTx Holdings plc3.6MUS$39.6M+50,000Sep 30, 2026
TG Therapeutics, Inc.557KUS$31.1M+22,000Sep 30, 2026
Alpha Cognition Inc.3.3MUS$29.7M+408KSep 30, 2026
Immix Biopharma, Inc.2.83MUS$29.4M+480KSep 30, 2026
Crescent Biopharma, Inc.1.65MUS$24M+327KSep 30, 2026
Verastem, Inc.2.75MUS$22.2M+953KSep 30, 2026